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ABSTRACT 
Veterinarian and human pharmaceuticals may be intentionally added to animal feed to 
enhance animal production. Monitoring these substances is necessary for protecting the 
consumers. In this work, a screening method covering 116 human and veterinary drugs 
has been developed and validated in five types of animal feed at 0.02 and 0.2 mg kg-1. 
After a simple extraction with acetonitrile (1% formic acid) and subsequent ten-fold 
dilution with water, the sample extracts were analyzed by ultra-high performance liquid 
chromatography coupled to quadrupole time-of-flight mass spectrometry (UHPLC-
QTOF MS). Nearly all compounds tested were detected at 0.02 mg kg-1, based on the 
presence of the accurate-mass protonated molecule. The reliable identification of the 
compound using a second accurate-mass (fragment) ion was however more problematic 
at this level due to the lower abundance of the second ion in the mass spectra. In a 
subsequent step, the procedure was applied to 22 feed samples, where compounds as 
trimethoprim, robenidine, or - and β-nandrolone were detected and identified. The 
potential applicability of the method to quantitative analysis of the compounds detected 
in the samples was also evaluated. 
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1. INTRODUCTION 
Over the last decades, livestock production has increased notably, mainly due to 
intensive farming. Veterinary drugs have been extensively used in animal husbandry, 
both for prophylactic and therapeutic purposes (Lopes, De Freitas Passos, De Alkimim 
Filho, Vargas, Augusti & Augusti, 2012). It is estimated that 6051 tons of various active 
substances are used as veterinarian medicines in the European Union to enhance animal 
production (Kools, Moltmann & Knacker, 2008). Human pharmaceuticals (especially 
antibiotics) can also be added to animal feed, because of their commercial availability 
and low cost. In this context, pharmaceutical dosing must be carefully monitored to 
achieve a compromise between the agronomic results and the negative environmental 
and sanitary consequences of releasing these drugs to agro ecosystems (Granados-
Chinchilla, Sánchez, García & Rodríguez, 2012). The control of these substances is also 
necessary for protecting the consumers. Animal feeds must have the required quality 
and be appropriate from a nutritional point of view. They must be safe, i.e., free from 
contaminants and residues in general, and from residues of veterinary drugs in particular. 
The case of antimicrobials is of particular concern, as they might provoke allergies and 
contribute to the development of resistant bacterial strains if they reach the food chain 
(Borràs et al., 2011). 
Some substances are banned, while others are authorized as long as their 
concentrations in food of animal origin remain below certain established limits. Thus, 
Directive 2002/32/EC regulated the measures on undesirable substances in animal feed 
(European Commission, 2002a). Regulation (EC) 1831/2003 banned the use of all 
antibiotics other than coccidiostatics and histomonostats as feed additives from 1 
January 2006 (European Commission, 2003). Recently, Directive 2009/8/EC 
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established maximum levels of unavoidable carry-over for these compounds in non-
target feed (European Commission, 2009). 
Drugs can reach feeds in three ways: authorized drugs (for therapeutic and 
prophylactic purposes), unauthorized drugs (as grow promoters to increase yield) and 
unintentional (as a result of the so-called cross-contamination) (Borrás, Ríos-
Kristjánsson, Companyõ & Prat, 2012). Although several different analytical methods 
based on liquid chromatography coupled to fluorescence or ultraviolet detection have 
been developed, the most recent methodology relies on mass spectrometry (Capitan-
Vallvey, Ariza, Checa & Navas, 2007, Kot-Wasik & Wasik, 2005) or, preferably, 
tandem mass spectrometry detection with triple quadrupole (Boscher, Guignard, Pellet, 
Hoffmann & Bohn, 2010, Cronly et al., 2010, De Baere & De Backer, 2007, Van 
Holthoon, Mulder, Van Bennekom, Heskamp, Zuidema & Van Rhijn, 2010, Vincent, 
Chedin, Yasar & von Holst, 2008) or ion trap analyzers (Kantiani, Farré, Freixiedas & 
Barceló, 2010, Xu et al., 2011), because of the high selectivity and sensitivity provided 
by this technique. However, most of methods developed until now deal with a limited 
number of compounds, generally belonging to the same family. Among the most 
studied are the quinolones antimicrobials (Borrás, Ríos-Kristjánsson, Companyõ & Prat, 
2012, Boscher, Guignard, Pellet, Hoffmann & Bohn, 2010, Xu et al., 2011), 
sulfonamides (Kantiani, Farré, Freixiedas & Barceló, 2010, Lopes, De Freitas Passos, 
De Alkimim Filho, Vargas, Augusti & Augusti, 2012), macrolides (Boscher, Guignard, 
Pellet, Hoffmann & Bohn, 2010), β-lactams (Boscher, Guignard, Pellet, Hoffmann & 
Bohn, 2010, Kantiani, Farré, Freixiedas & Barceló, 2010, Van Holthoon, Mulder, Van 
Bennekom, Heskamp, Zuidema & Van Rhijn, 2010) or tetracyclines (Boscher, 
Guignard, Pellet, Hoffmann & Bohn, 2010, Granados-Chinchilla, Sánchez, García & 
Rodríguez, 2012). In these cases, specific sample treatments are normally applied. 
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The large number of available drugs has caused an increase in the number of 
analytes to be monitored. Under this situation, it is advisable to perform sample 
extractions as generic as possible in order to widen the scope of the method and to 
include as many analytes as possible. For large screening purposes, an alternative to 
MS/MS is the application of full scan techniques based on high resolution mass 
spectrometry (HRMS), using QTOF (Deng et al., 2011, Nácher-Mestre, Ibáñez, Serrano, 
Pérez-Sánchez & Hernández, 2013, van der Heeft, Bolck, Beumer, Nijrolder, Stolker & 
Nielen, 2009, Villar-Pulido, Gilbert-López, García-Reyes, Martos & Molina-Díaz, 2011) 
or Orbitrap (Kaufmann, Butcher, Maden, Walker & Widmer, 2011, van der Heeft, 
Bolck, Beumer, Nijrolder, Stolker & Nielen, 2009) analyzers, which have opened new 
possibilities for analysis of many different organic contaminants/residues in matrices 
like milk (Freitas, Paim & de Souza e Silva, 2013, Stolker et al., 2008) urine (León, 
Roca, Igualada, Martins, Pastor & Yusá, 2012), water (Diaz, Ibáñez, Sancho & 
Hernández, 2013) or feed (Aguilera-Luiz, Romero-González, Plaza-Bolaños, Martínez 
Vidal & Garrido Frenich, 2013, Martínez-Villalba, Vaclavik, Moyano, Galceran & 
Hajslova, 2013, Nácher-Mestre, Ibáñez, Serrano, Pérez-Sánchez & Hernández, 2013). 
As illustrative examples, Martínez et al. (Martínez-Villalba, Vaclavik, Moyano, 
Galceran & Hajslova, 2013) and Nácher et al. (Nácher-Mestre, Ibáñez, Serrano, Pérez-
Sánchez & Hernández, 2013) carried out a qualitative validation for chicken and fish 
feed, respectively, using HRMS. Aguilera et al. (Aguilera-Luiz, Romero-González, 
Plaza-Bolaños, Martínez Vidal & Garrido Frenich, 2013), made the validation for 
around 60 veterinary drugs and 150 pesticides in chicken, hen, rabbit and horse feed. 
The objective of this work is to investigate the potential of UHPLC coupled to 
hybrid analyzer QTOF MS for large screening (i.e. detection and identification of the 
compound detected) of human and veterinary drugs in different animal feeds (bovine, 
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rabbit, poultry, goat and pork). This analyzer allows to work under MS
E
 mode, which 
allows the simultaneous acquisition of accurate-mass full-spectrum acquisition data at 
low (LE) and high (HE) collision energy. MS
E
 mode provides useful information on the 
parent molecule (commonly the (de)protonated molecule, in the LE function, as this is 
the main ion observed in electrospray source under negative or positive ionization 
mode), and on the main fragment ions (commonly in the HE function, where 
fragmentation is promoted) (Diaz, Ibáñez, Sancho & Hernández, 2013; Hernández, 
Bijlsma, Sancho, Díaz & Ibáñez, 2011). A subset of around 120 compounds from 
different chemical families has been selected for evaluation of the screening 
methodology. Once validated, the screening has been widened to search for around 530 
additional pharmaceuticals, which reference standards were unavailable in our 
laboratory, and applied to 22 commercial feed samples to test its applicability. The 
possibilities to perform quantitative analysis for those positive pharmaceuticals found in 
animal feeds using the same instrument have been also evaluated. 
 
2. EXPERIMENTAL 
2.1. Reagents and chemicals 
Reference compounds (Table S1) were purchased from Fort Dodge Veterinaria 
(Gerona, Spain), Vetoquinol Industrial (Madrid, Spain), Aventis Pharma (Madrid, 
Spain), Sigma Aldrich (St Louis, MO, USA), Cerilliant (Round Rock, TX, USA), Dr. 
Ehrenstorfer (Augsburg, Germany), Riedel-de Haën (Seelze, Germany), National 
Measurement Institute (Pymble, Australia), Witega (Berlin, Germany), and Fluka 
(Buchs, Switzerland). All reference materials had purities higher than 98% (w/w), 
except for marbofloxacin and pefloxacin, which had purities higher than 93%. 
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Isotopically labelled internal standards (ILIS) fenilbutazone-d10, robenidine-d8, 
4,4’dinitrocarbanilide-d8 (DNC-d8), amphetamine-d6, benzoylecgonine-d3 and 
carbamazepine epoxide-d10 were obtained from Cerilliant, and CDN Isotopes (Quebec, 
Canada). 
HPLC-grade methanol (MeOH), acetonitrile (ACN) and sodium hydroxide 
(>99%) were purchased from ScharLab (Barcelona, Spain). Formic acid (HCOOH) 
(>98% w/w) was obtained from Fluka. Leucine enkephalin was purchased from Sigma 
Aldrich. HPLC-grade water was obtained from deionized water passed through a Milli-
Q Gradient A10 (18.2 MΩ cm) water puriﬁcation system (Millipore, Bedford, MA, 
USA). 
2.2. Instrumentation 
An Acquity ultra-performance liquid chromatography (UPLC) system (Waters, 
Milford, MA, USA) was interfaced to a QTOF mass spectrometer (QTOF Xevo G2, 
Waters Micromass, Manchester, UK) using an orthogonal Z-spray electrospray interface. 
The LC separation was performed using Acquity UPLC BEH C18 1.7 µm particle size 
analytical column of 100 x 2.1 mm (from Waters), at a ﬂow rate of 0.3 mL min-1. The 
mobile phases used were A H2O and B MeOH, both with 0.01% (v/v) HCOOH. The 
percentage of MeOH was linearly increased as follows: 0 min, 10%; 14 min, 90%; 16 
min, 90% and 16.01 min, 10%. The total run time was 18 min. The injection volume 
was 50 μL. Nitrogen (Praxair, Valencia, Spain) was used as both the drying gas and the 
nebulising gas. The desolvation gas ﬂow rate was set at 1000 L h-1. The resolution of 
the TOF mass spectrometer was ~20 000 at full width half maximum (FWHM) at m/z 
556. MS data were acquired over a m/z range of 50–1200 in a scan time of 0.3 s. 
Capillary voltages of 0.7 kV and -1.7 kV were used in positive and negative ionization 
modes, respectively. A cone voltage of 25 V was applied. The collision gas was argon 
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(99.995%, Praxair). The interface temperature was set to 650 ºC and the source 
temperature to 130 ºC. The column temperature was set to 40 ºC and the samples to 5 ºC. 
For MS
E
 experiments, two acquisition functions with different collision energies were 
created: the low-energy (LE) function with a collision energy of 4 eV, and the high 
energy (HE) function with a collision energy ramp ranging from 15 to 40 eV. The same 
cone voltage (25 V) and collision energy ramp was used for additional MS/MS 
experiments. 
Calibration of the mass-axis from m/z 50 to 1200 was conducted daily with a 1:1 
mixture of 0.05M NaOH/5% (v/v) HCOOH diluted (1:25) with water/ACN (20:80 v/v). 
For automated accurate mass measurement, the lock-spray probe was employed, 
using as lockmass leucine enkephalin (2 mg L-1) in ACN/water (50/50) at 0.1% 
HCOOH, pumped at 20 µL min-1 through the lock-spray needle. The leucine 
enkephalin [M+H]
+
 ion (m/z 556.2771) and its fragment ion (m/z 278.1141) for positive 
ionization mode, and [M-H]
-
 ion (m/z 554.2615) and its fragment ion (m/z 236.1035) for 
negative ionization, were used for recalibrating the mass axis and to ensure a robust 
accurate mass measurement over time. 
The data station operating software was MassLynx version 4.1 (Waters). 
2.3. Feed samples 
A total of 10 different feed samples were used for method validation (2 bovine, 2 
rabbit, 2 poultry, 2 goat and 2 pork). 
In a subsequent step, the developed procedure was applied to other feed samples 
to test its applicability. 22 feed samples (12 bovine, 3 rabbit, 2 poultry, 2 goat and 3 
pork) were collected in polyethylene high-density bottles from farms located in Spanish 
Mediterranean area (Valencia and Castellon provinces). Samples were stored at −18 ºC. 
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Before analysis, samples were thawed at room temperature and triturated with a crusher 
Super JS from Moulinex (Bagnolet Cedex, France).  
2.4. Extraction procedure 
Five grams of homogenized feed sample were accurately weighed (precision 0.1 
mg)  directly in centrifuge tubes (50 mL) and extracted with 10 mL of acetonitrile 1% 
HCOOH, using a vortex for 1 minute. Then, the mixture was mechanically shaken end-
over-end for 1 hour. After that, samples were sonicated (15 minutes) and centrifuged at 
4500 r.p.m for 10 min. A 2-mL aliquot of supernatant was transferred to an Eppendorf 
tube, and a second centrifugation was performed at 12000 r.p.m (12074 x g) for 10 min. 
Finally, the extract was ten-fold diluted with Milli-Q water (100 µL extract + 900 µL 
water) and injected in the system. No microfiltration was made to avoid potential losses 
of compounds in this step. 
2.5. Qualitative validation protocol 
In this work, method validation was performed following the strategy described 
in the literature (Diaz, Ibáñez, Sancho & Hernández, 2013, Nácher-Mestre, Ibáñez, 
Serrano, Pérez-Sánchez & Hernández, 2013). 
Ten different animal feeds (five types of matrices, two feed samples for each 
matrix) were spiked with a mix solution of the test analytes in methanol at two levels, 
0.02 mg kg-1 and 0.2 mg kg-1, let stand overnight, and analyzed together with their 
non-spiked samples (blanks). The final concentrations in the ten-fold diluted extracts 
were 1 and 10 µg L-1, respectively. 
The screening detection limit (SDL) and the limit of identification (LOI) were 
investigated as the main validation parameters to estimate the threshold concentration at 
which detection and identification become reliable, respectively. The SDL was 
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established as the lowest concentration level tested for which a compound was detected 
in all samples, using the most abundant ion (typically, the (de)protonated molecule) 
measured at its exact mass (mass error lower than ±2 mDa) and at the expected 
retention time (±2.5% RT deviation tolerance). The LOI was established as the lowest 
concentration tested for which a compound was satisfactorily identified in all spiked 
samples. The identification criterion was the presence of, at least, two m/z ions in either 
the LE or HE function at the expected retention time measured at their exact mass.  
The terms SDL and LOI would be equivalent to the definition of “screening 
target concentration” and “detection capability”, respectively, provided by the CRL´s 
2010 guideline (CRLs 2010). 
 
3. RESULTS AND DISCUSSION 
3.1. Database building 
A large number of pharmaceuticals, which could be potentially present in animal 
feed, were selected as target compounds, with m/z values ranging from 137.0239 ([M-
H]
-
 ion of salicylic acid) to 934.5739 ([M+H]
+
 ion of maduramicine). For those 
pharmaceuticals which reference standard was available in our lab (116 compounds), 
empirical data was obtained after injection into the UHPLC-QTOF MS, following the 
working conditions reported in Diaz et al, 2011 (Díaz, Ibáñez, Sancho & Hernández, 
2011). These compounds were afterwards used in the validation experiments. Table S1 
shows the compound name, ionization mode, retention time (min.) and exact mass for 
(de)protonated compounds, and the elemental compositions for their main fragment ions. 
93 out of 116 analytes were detected in positive ionization mode, whereas 9 were in 
negative mode; 14 compounds were detected in both modes. For the remaining 
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compounds, which standards were unavailable (530 approx.), information on elemental 
composition was included in the database, for future screening in real samples. The 
database included anabolic substances (such as thyrostatic compounds, stilbenes, 
stilbenes derivatives, 17-β-estradiol and ester derivatives) as well as β-agonists, 
prohibited according to (European Commission, 2008). Compounds with maximum 
levels established (coccidiostatics and histomonostats) (European Commission, 2002a) 
and other veterinarian and human pharmaceuticals not regulated, mainly antimicrobials, 
were also included. 
3.2. Qualitative validation results 
Five different feed matrices were tested in method validation: bovine, rabbit, 
poultry, goat and pork. Two samples of each type were spiked with the mix of 116 
pharmaceuticals at two concentration levels (0.02 and 0.2 mg kg-1). These levels were 
selected accordingly with the feed regulation (Bruni & Ferreira, 2008). Table S2 shows 
the SDL and LOI obtained for each analyte in each matrix. A summary of this table is 
also shown in Figure S1. As it can be seen, around 75% of compounds could be 
detected at 0.2 mg kg-1 (see accumulated, Figure S1) while the percentage of detection 
decreased down to 40% at 0.02 mg kg-1. It is noteworthy the great differences observed 
between the matrices studied. As shown in Figure S2, significant differences in the 
signal response (e.g. in sensitivity) were found between standards in solvent and in the 
five feed samples (all at a concentration of 0.2 mg kg-1), as illustrated for six of the 
compounds investigated. This made that, although around between 90% of the 
compounds were detected in each matrix individually at 0.2 mg kg-1, only 75% could 
be fully validated at this level, i.e. only 75% were detected in all matrices. The highest 
number of compounds detected corresponded to poultry and pork feeds (around 70 
pharmaceuticals). On the contrary, bovine, rabbit and goat feeds appeared as the most 
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problematic matrices, which may be considered more complex than others, likely due to 
their different fatty content (Aguilera-Luiz, Romero-González, Plaza-Bolaños, Martínez 
Vidal & Garrido Frenich, 2013). Nine pharmaceuticals (diethylstilbestrol, 16-β-
hydroxystanozolol, amoxicillin, cefaclor, cefadroxil, cephalexin, abamectine, 
doramectine and omeprazole) were not detected in any of the spiked samples. These 
compounds might not be stable under the extraction conditions assayed or might be 
highly affected by matrix effects.  
Overall, the reliable identification using two accurate-mass ions was feasible for 
55% of compounds at 0.2 mg kg-1. This value drastically decreased down to 10% at 
0.02 mg kg-1, showing the great difficulties to obtain a second ion at low analyte 
concentration in this type of matrices. Regarding poultry and pork feeds around 40% of 
compounds could be identified at the lower level; yielding more than 70% of the 
pharmaceuticals identified at 0.2 mg kg-1. The apparently more complex goat, rabbit 
and bovine feed matrices allowed the identification of around 60% of the compounds 
analyzed at the 0.2 mg kg-1 level. Concentrations higher than 0.2 mg kg-1 were not 
tested. Surely, most of compounds which were detected but could not be identified at 
0.2 mg kg-1 because of the low sensitivity for its fragment ion might be identified at 
higher concentration levels. 
In this work, typically the (de)protonated molecule and at least one collision 
induced dissociation (CID) fragment ion, in either, the LE or HE functions, were used 
for detection and identification, respectively. However, several compounds presented 
poor or none fragmentation as result of the compromise collision energy ramp applied. 
This was the case of ivermectin or ipromidazole, amongst others. In those cases, when 
fragment ions were not observed, only SDL could be set-up (12 out of 116 compounds).  
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Table 1 shows the total SDL for the 10 samples under study (i.e. SDL means 
detected in all 10 samples analyzed), and illustrates the applicability of the screening for 
detection of veterinary drugs.. 
3.3. Application to routine samples 
A total of twenty two feed samples (12 bovine, 3 rabbit, 2 poultry, 2 goat and 3 
pork) were analyzed following the developed procedure in order to evaluate its 
applicability. Up to 11 compounds were detected and properly identified. Table 2 
shows a summary of the results obtained.  
The most detected compounds were the salicylic acid, active metabolite of anti-
inflammatory acetylsalicylic acid (aspirin), and the antimicrobial trimethoprim, which 
were found in 50% of the samples analyzed. As an illustrative example, Figure S3 
shows the HE spectra of a reference standard of trimethoprim and a positive poultry 
feed sample. As it can be seen, both spectra perfectly matched, sharing up to 8 main 
fragment ions with mass errors lower than 2 mDa, at the expected retention time (3.6 
min). Figure 1 shows another example, the detection and identification of the antibiotic 
lincomycin in a pork feed sample. In this case, the ions corresponding to the protonated 
molecule and to its unique fragment ion (at m/z 407.2216 and m/z 126.1283, 
respectively) at the expected retention time were observed. In addition to the presence 
of the two ions with acceptable mass errors, the intensity ratio between the most 
abundant ion (i.e. the protonated molecule) and the fragment ion used for confirmation 
was also calculated obtaining a deviation of 1.3% in relation to the reference standard. 
This deviation was by far lower than the ± 20% allowed by the EU guidelines for ion 
ratios between 1 and 2, giving even more reliability to the confirmation process 
(European Commission, 2002b). 
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Up to 4 tetracyclines (chlortetracycline, oxytetracycline, tetracycline and 
doxycycline) were found in several matrices, the highest levels being found in one of 
the pork feeds particularly oxytetracycline (Table 2). 
The antibiotic florfenicol was also identified in 2 bovine samples. This 
antimicrobial is currently indicated for the treatment of bovine respiratory diseases 
(European Medicines Agency,2009).  
The detection of robenidine, a coccidiostat used for the control of protozoal 
infection, and regulated in the European Commission Directive EC 2009/8 (European 
Commission, 2009) was also of interest. This compound was detected in one bovine and 
two rabbit feed samples. Figure 2 illustrates the identification and quantification of this 
pharmaceutical in rabbit feed. As it can be seen, not only the protonated molecule but 
also two fragment ions were observed at the expected retention time. Robenidine-d8 was 
used as isotope-labeled internal standard (ILIS) to compensate for matrix affects as well 
as possible variations in the instrument measurement. The concentration calculated for 
this sample was 40.4 mg kg-1 (see next section for more details). Although this value by 
far exceeds the maximum content of 0.7 mg kg-1 established by the Directive 
(European Commission, 2010), a subsequent Commission Regulation (Commission 
implementing Regulation (EU) No 532/2011 of 31 May 2011 concerning the 
authorization of robenidine hydrochloride as a feed additive for rabbits for breeding and 
rabbits for fattening (holder of authorization Alpharma Belgium BVBA) and amending 
Regulations (EC) No 2430/1999 and (EC) No 1800/2004) concerning the authorization 
of robenidine hydrochloride as a feed additive for rabbits for breeding and rabbits for 
fattening, establishes the maximum content in 66 mg of active substance kg-1 of 
complete feeding stuff, until June 2021 (European Commission, 2011). 
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The most remarkable was the detection of the steroids -nandrolone and β-
nandrolone, found in 7 and 1 out of 22 feed samples analyzed, respectively (Table 2). 
These compounds were banned by Directive 2008/97/EC European Parliament and of 
the Council of 19 November 2008 amending Council Directive 96/22/EC concerning 
the prohibition on the use in stock farming of certain substances having a hormonal or 
thyrostatic action and of beta-agonists (European Commission, 2008). The identification 
of the hormone -nandrolone in bovine feed is shown in Figure 3, where the protonated 
molecule and two fragment ions were detected in the LE function. To support the 
confirmation of its identity, the intensity ratio was calculated too, obtaining a deviation 
of -44% for the main fragment ion (F1) which is lower than ± 50% allowed by the EU 
guidelines for ion ratios ≥ 10 (European Commission, 2002b). 
Although the LOI could not be established to be 0.2 mg kg-1 for some 
compounds (i.e., the compound could not be identified at this level in spiked samples), 
they were however identified in the feed samples analyzed. This means that their 
concentration in the samples was above the levels tested for LOI (0.02 and 0.2 mg kg-1). 
This was the case of chlortetracycline in poultry feed, doxycycline in rabbit and pork 
feed, tetracycline in poultry and bovine feed, and salicylic acid in poultry, bovine, rabbit 
and pork feed. With the data available from QTOF MS analysis, the identification of 
these compounds in the samples was certainly highly reliable.  
In case of detecting a compound whose reference standard was not available in 
the laboratory, its tentative identification would be based on the ions observed 
(protonated molecule and fragment ions), their compatibility with the chemical structure 
of the candidate, and on the comparison with those ions reported in the literature (Diaz, 
Ibáñez, Sancho & Hernández, 2013; Díaz, Ibáñez, Sancho & Hernández, 2012). In the 
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present work, for all compounds detected in feed the reference standards were all 
available in our laboratory. 
  3.4. Evaluation of the applicability to quantitative analysis 
Finally, an evaluation of the applicability of the screening to quantitative 
analysis was made for the compounds found in the feed samples: β-nandrolone, 
robenidine, chlortetracycline, tetracycline, oxytetracycline, doxycycline, lincomycin, 
trimethoprim, florfenicol and salicylic acid. This investigation was not possible for α-
nandrolone due to the lack of reference standard at sufficiently high concentration (a 
mixture of several standards, at around 10 mg L-1, was only available for this 
compound as a gift from the Laboratory of Public Health of Valencia).  
For this purpose, bovine, poultry and pork feeds were spiked by triplicate at 0.2 
and 2 mg kg-1. Those feeds previously analyzed and proven to not contain the analytes 
were selected as “blanks” to perform recovery experiments (one feed for each matrix by 
triplicate). In addition to spiked samples, “blank” samples, spiked only with an ILIS 
mix, were also processed to subtract the responses of possible positive compounds. 
Quantification was performed using calibration standards in solvent and relative 
responses to ILIS for matrix effects correction. Unfortunately, robenidine was the only 
analyte among all tested for which its labeled compound (robenidine-d8) was available 
at our laboratory. After several preliminary experiments, for the rest of compounds we 
selected other available ILIS that seemed to roughly compensate the matrix effect 
observed (Table S3). 
The linearity of the method was studied in the range 1-250 µg L-1 for all 
selected compounds obtaining satisfactory correlation coefficients (greater than 0.99). 
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Regarding robenidine, satisfactory recoveries (61-93%) and precision (1-6%) 
were obtained at 0.2 mg kg-1 spiked level for the three matrices, and also at 2 mg kg-1 
(recovery 90-98%, precision 3-6%) (Table S3). Nevertheless, for the other compounds, 
recoveries were not completely satisfactory in all matrices although they mostly varied 
between 60-120%. Tetracyclines could only be validated in pork feed at the highest 
level assayed. With few exceptions, RSD were satisfactory (below 15%) except for 
chlortetracycline in pork, and salicylic acid in bovine and poultry. It seemed that the 
analyte-labeled ILIS was required to ensure appropriate correction due to the strong 
matrix effect resulting from the matrix complexity and little sample manipulation.  
Figure S2 shows the responses for six pharmaceuticals in solvent and in five feed 
matrices spiked at 0.2 mg kg-1, illustrating the large signal differences observed 
between each feed matrix. Matrix effects correction using ILIS other than the labeled 
analyte was not always assured. Based on the experiments performed, we quantified the 
compounds detected in the samples only for those matrices previously tested, which  
recoveries ranged between 60 and 120% with RSD < 15% (see Table 2). Although 
rabbit feed was not tested in recovery experiments, a high robenidine concentration of 
40.4 mg kg-1 could be reported due to the satisfactory recovery obtained in other 
matrices and to the availability of analyte ILIS. 
The objective of the present work was to investigate the potential of LC-QTOF 
MS for screening of veterinary drugs. In the case that this methodology was finally used 
by reference laboratories and for official purposes, the appropriate guidelines should be 
taken into account, as for example the one established for community reference 
laboratories residues (CRLs 2010), or other guidelines applied in related fields 
(European Commission, 2013). 
 
19 
 
4. CONCLUSIONS  
In this article, a multiclass, wide-scope, and rapid screening based on UHPLC-QTOF 
MS has been developed for human and veterinary pharmaceuticals in five types of 
animal feeds (bovine, rabbit, poultry, goat and pork). After extraction of the sample 
with acidified acetonitrile and direct analysis by QTOF MS, the wide majority of the 
116 compounds tested were detected and correctly identified in all feed samples spiked 
at 0.2 mg kg-1. Detection, based on the presence of the (de)protonated molecule, was 
also feasible in most cases at the lowest level tested (0.02 mg kg-1), although 
identification using a second accurate-mass fragment ion, was problematic at this 
concentration due to the complexity of the sample matrices. 
The screening procedure was applied to 22 feed samples, with the result of detecting 
and correctly identifying several antibiotics, such as florfenicol, robenidine or 
lincomycin; one of them, robenidine, included in the current legislation. Moreover, two 
hormones, - and β- nandrolone, banned by the directive (European Commission, 2008), 
were also found in some feeds. Trimethoprim and salicylic acid, were the compounds 
more detected (50%) followed by lincomycin and α-nandrolone (32%).  
The strong potential of LC-QTOF MS for wide-scope screening of veterinary drugs in 
feed has been proven in this work. Although the main applications of QTOF MS are 
directed towards detection and identification of the compounds, this technique might be 
also used for quantitative purposes. To explore this possibility, a preliminary work has 
been made with the compounds that were detected in the previous screening obtaining 
promising results. The availability of robenidine-d8 used as ILIS allowed the reliable 
quantification of robenidine in the samples analyzed, thanks to the satisfactory matrix 
effects correction, as demonstrated by the satisfactory recoveries and precision obtained 
at 0.2 and 2 mg kg-1 spiked levels. This compound was found in two rabbit feeds with a 
20 
 
maximum concentration of 40.4 mg kg-1. In the light of the results obtained in this 
work, a quantitative analysis might be also feasible using LC-QTOF MS, although more 
work is required to fully explore this possibility. This technique, similarly to the most 
widely used for quantitative analysis in this field (i.e. LC-MS/MS), is notably affected 
by matrix effects, and therefore the use of ILIS greatly facilitates an accurate 
quantification. 
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FIGURE CAPTIONS 1 
Figure 1. (a) Lincomycin and its fragment ion structure. nw-XICs corresponding to the 2 
protonated molecule at LE and to its fragment ion at HE for (b) 0.1 mg L-1 reference 3 
standard and (c) positive pork feed sample. 4 
Figure 2. Positive finding of the coccidiostatic robenidine in a rabbit feed. (a) nw-XICs 5 
at 20 mDa mass window for the protonated molecule at LE and its two main fragment 6 
ions at HE. (b) Calibration curve obtained using relative responses, with robenidine-d8 7 
as internal standard. 8 
Figure 3. Positive finding of -nandrolone in a bovine feed. nw-XICs at 20 mDa mass 9 
window for the protonated molecule and two fragment ions at LE for (a) reference 10 
standard and (b) bovine feed. 11 
 12 
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Table 1. Screening Detection Limit (SDL) and Limit Of Identification (LOI) (both in mg Kg-1) for 
studied compounds.  
 
 
 
 
 
 
Stilbenes SDL LOI Nitromidazoles SDL LOI 
Amphenicols 
(cont.) 
SDL LOI 
Dienestrol >0.2 >0.2 Chloramphenicol 0.02 0.2 Florfenicol 0.2 >0.2 
Hexestrol >0.2 >0.2 Dimetridazole (DMZ) 0.02 >0.2 Florfenicol amine >0.2 >0.2 
Steroids SDL LOI Furaltadone 0.2 >0.2 Flumequine 0.02 0.2 
∆1,4-Androstadiene-
3,17-dione (Boldione) 
>0.2 >0.2 
Hydroxy Dimetridazole 
(HMMNI) 
>0.2 >0.2 Lincomycin 0.02 0.2 
α-Boldenone 0.02 0.2 
Hydroxyipronidazole 
(IPZOH) 
0.02 0.02 Nalidixic acid 0.02 0.2 
α-Nandrolone 0.02 >0.2 
Hydroxymetronidazole 
(MNZOH) 
>0.2 >0.2 Norfloxacin 0.2 0.2 
Androstenediol (AED) >0.2 >0.2 Ipronidazole (IPZ) 0.2 >0.2 Ofloxacin 0.2 0.2 
β-Boldenone 0.2 >0.2 Metronidazole (MNZ) >0.2 >0.2 Oxacillin 0.2 >0.2 
β-Nandrolone 0.2 0.2 Ronidazole (RNZ) >0.2 >0.2 Oxolinic acid 0.2 0.2 
Stanozolol 0.02 >0.2 Amphenicols SDL LOI Oxytetracycline >0.2 >0.2 
RALs SDL LOI Ampicillin 0.2 >0.2 Pefloxacin 0.02 0.2 
α-Zeranol >0.2 >0.2 Cefotaxim 0.2 0.2 Penicillin G 0.2 0.2 
β-Zeranol 0.2 >0.2 Ceftriaxone >0.2 >0.2 Pipedimic acid 0.2 0.2 
Zearalanone (ZAN) >0.2 >0.2 Cefuroxime >0.2 >0.2 Piperacillin 0.2 0.2 
β-Agonists SDL LOI Chlortetracycline  >0.2 >0.2 Roxythromycin 0.02 0.2 
Brombuterol 0.02 0.2 Ciprofloxacin 0.2 0.2 Sarafloxacin 0.2 >0.2 
Clenbuterol 0.02 0.2 Clarithromycin 0.02 0.02 Sulfadoxine 0.02 0.2 
Clenpenterol 0.02 0.2 Cloxacillin 0.2 0.2 Sulfamethoxazole 0.02 0.2 
Hydroxymethyl 
clenbuterol 
0.02 0.02 Dicloxacillin 0.2 >0.2 Tetracycline >0.2 >0.2 
Mabuterol 0.02 0.02 Doxycycline >0.2 >0.2 Thiamphenicol 0.2 >0.2 
Mapenterol 0.02 0.02 Enrofloxacin 0.2 0.2 Trimethoprim 0.02 0.02 
Ractopamine 0.02 0.2 Erythromycin A 0.2 >0.2    
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Table 1 (cont). Screening Detection Limit (SDL) and Limit Of Identification (LOI) (both in mg Kg-1) for 
studied compounds.  
 
Avermectins SDL LOI NSAIDs SDL LOI 
Other 
pharmaceuticals 
SDL LOI 
Emamectin B1a 0.2 0.2 4-acetylamino-antipyrine 0.02 0.2 Acetaminophen >0.2 >0.2 
Eprinomectin 0.2 >0.2 4-amino-antipyrine  >0.2 >0.2 Atorvastatin 0.2 >0.2 
Ivermectin >0.2 >0.2 4-formylamino-antipyrine 0.2 0.2 Bezafibrate 0.2 >0.2 
Levamisole 0.02 0.2 Diclofenac 0.2 0.2 Carbamazepine 0.02 >0.2 
Moxidectin >0.2 >0.2 Ibuprofen >0.2 >0.2 Enalapril 0.02 0.2 
Coccidiostats SDL LOI Ketoprofen 0.02 0.2 Gemfibrozil 0.2 0.2 
Maduramicine 0.02 0.2 Mefenamic acid 0.02 0.2 Irbesartan 0.02 0.2 
Monensin 0.2 0.2 Naproxen 0.2 >0.2 Lorazepam 0.2 0.2 
Narasin 0.02 >0.2 Oxyphenylbutazone 0.2 >0.2 Olanzapine 0.2 0.2 
Robenidine 0.02 0.2 Phenylbutazone >0.2 >0.2 Pantoprazole >0.2 >0.2 
Salinomycin 0.2 >0.2 Salicylic acid 0.02 >0.2 Pravastatin 0.2 0.2 
Sedatives SDL LOI Corticoids SDL LOI Valsartan 0.2 0.2 
Acepromazine 0.02 0.2 Betamethasone/Dexamethasone 0.2 >0.2 Venlafaxine 0.02 0.02 
Alprazolam 0.02 0.2 Flumethasone 0.2 >0.2  
  
Azaperol 0.02 >0.2 Methylprednisolone >0.2 >0.2  
  
Azaperone 0.02 0.2 Parasiticide SDL LOI  
  
Carazolol 0.02 0.02 Leucomalachite green >0.2 >0.2  
  
Chlorpromazine 0.02 0.02 Malachite green 0.2 0.2  
  
Propionilpromazine 
(combelen) 
0.02 0.2     
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Table 2. Positives found in 22 feed samples analyzed by UHPLC-QTOF MS. 1 
 2 
Positive findings 
Compound 
Bovine (n=12) Rabbit (n=3) Poultry (n=2) Goat (n=2) Pork (n=3) 
Number of 
positive 
findings 
Conc 
(mg kg-1) 
Number of 
positive 
findings 
Conc 
(mg kg-1) 
Number of 
positive 
findings 
Conc 
(mg kg-1) 
Number of 
positive 
findings 
Conc 
(mg kg-1) 
Number of 
positive 
findings 
Conc 
(mg kg-1) 
α-Nandrolone 2  -  2  1  2  
β-Nandrolone 1 0.3 -  -  -  -  
Robenidine 1 <0.2 2 40.4,31.2 -  -  -  
Chlortetracycline 1  -  1  -  -  
Oxytetracycline -  2  -  -  1 52.4 
Tetracycline 1  -  1  -  1 1.7 
Doxicycline -  1  -  -  1 18.7 
Lincomycin 1 22.2 2  -  1  3  
Trimethoprim 5  2  1  1 1.2 2  
Florfenicol 2 0.5,0.4 -  -  -  -  
Salicylic acid 3 1.0 3  1  2  2  
Quantification was only made for those compounds and matrices previously tested, and proven to have satisfactory recovery (between 60 and 120%) and RSD (< 15%) 3 
 4 
 5 
 6 
 7 
 8 
 9 
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SUPPLEMENTARY INFORMATION 10 
Table S1. Retention time (Rt), ionization mode, elemental composition, exact mass of (de)protonated molecule and elemental composition of the main fragment/adduct ions 11 
used for identification of the compounds.   12 
Pharmaceutical 
Rt Ion Elemental 
composition 
[M+H]+ Fragment Fragment Fragment Fragment Fragment 
(min) mode /[M-H]- ion 1 ion 2 ion 3 ion 4 ion 5 
Stilbenes 
 
    
      
Dienestrol 11.2 - C18H18O2 265.1229 C17H14O2 C16H12O2 C6H6O C15H10O2 C12H12O 
Diethylstilbestrol  11.9 - C18H20O2 267.1385 C14H10O2 C16H16O2 C16H14O2 C15H11O2 C9H8O 
Hexestrol 11.3 - C18H22O2 269.1542 C9H12O C9H11O C9H10O C8H8O C7H7O 
Steroids                   
∆1,4-Androstadiene-3,17-dione (Boldione) 9.6 + C19H24O2 285.1855 - - - - - 
16-β-hydroxystanozolol 10.5 + C21H32N2O2 345.2542 C4H4N2 - - - - 
α-Boldenone 10.9 + C19H26O2 287.2011 C19H24O C10H14 C19H26O2Na C19H26O2K C8H8O 
α-Nandrolone 11.0 + C18H26O2 275.2011 C18H24O C10H12 C18H22 C11H12 C7H8O 
Androstenediol (AED) 12.9 + C19H30O2 291.2324 - - - - - 
β-Boldenone 10.2 + C19H26O2 287.2011 C19H26O2Na C19H24O C10H14 C19H26O2K C8H8O 
β-Nandrolone 10.3 + C18H26O2 275.2011 C18H24O C10H12 C18H22 C11H12 C7H8O 
Stanozolol 12.1 + C21H32N2O 329.2593 C7H10 C4H4N2 - - - 
Resorcylic acid lactones (RALs)               
α-Zeranol 10.5 - C18H26O5 321.1702 C17H26O3 C17H26O4 C18H24O4 C17H24O2 C15H24O2 
β-Zeranol 9.6 - C18H26O5 321.1702 C17H26O3 C18H24O4 C17H26O4 C17H24O2 C15H24O2 
Zearalanone (ZAN) 10.9 - C18H24O5 319.1545 C18H22O4 C17H24O3 C14H18O3 C12H14O3 C10H12O2 
β-Agonists                   
Brombuterol 5.6 + C12H18Br2N2O 364.9864 C12H16N2Br2 C8H8N2Br C8H8N2Br2 C8H7N2 
 
Clenbuterol 4.9 + C12H18Cl2N2O 277.0874 C8H7N2 C12H16N2Cl2 C8H8N2Cl2 C8H5NCl C8H9N2Cl 
Clenpenterol 5.9 + C13H20Cl2N2O 291.1031 C13H18N2Cl2 C8H8N2Cl2 C8H8N2Cl C8H5NCl C7H6NCl 
Hydroxymethyl clenbuterol 3.9 + C12H18Cl2N2O2 293.0824 C12H16N2OCl2 C8H8N2Cl C8H7N2 C8H8N2Cl2 - 
Mabuterol 5.8 + C13H18ClF3N2O 311.1138 C9H8N2F3Cl C9H7N2F2Cl C13H16N2F3Cl C9H8N2F3 C8H6NF2Cl 
Mapenterol 6.8 + C14H20ClF3N2O 325.1295 C9H8N2F3Cl C9H7N2F2Cl C9H8N2F3 C14H18N2F3Cl C9H6N2FCl 
Ractopamine 4.3 + C18H23NO3 302.1756 C8H8O C7H6O C18H21NO2 C10H13NO C8H9NO 
Nitromidazoles                   
Chloramphenicol 6.3 + C11H12Cl2N2O 323.0201 C11H10N2O4Cl2 C8H8N2O2 C11H11NaCl2N2O5 C8H8N C10H8N2O3Cl2 
    - C11H12N2O5Cl2 321.0045 C10H11N2O4Cl C9H9NO4 C7H7NO3 C9H7NO3 C10H10N2O5 
Dimetridazole (DMZ) 2.8 + C5H7N3O2 142.0617 C5H10N2O C4H8N3 C5H9N2 C4H6N2 C5H10N2 
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Pharmaceutical 
Rt Ion Elemental 
composition 
[M+H]+ Fragment Fragment Fragment Fragment Fragment 
(min) mode /[M-H]- ion 1 ion 2 ion 3 ion 4 ion 5 
Furaltadone 2.4 + C13H16N4O6 325.1148 C5H9NO C11H13N3O4 C7H13NO - - 
Hydroxy Dimetridazole (HMMNI) 2.1 + C5H7N3O3 158.0566 - - - - - 
Hydroxyipronidazole (IPZOH) 4.4 + C7H11N3O3 186.0879 C7H9N3O2 C7H9N2 C4H5N3O2 C6H6N2 C6H1N 
Hydroxymetronidazole (MNZOH) 1.8 + C6H9N3O4 188.0671 - - - - - 
Ipronidazole (IPZ) 5.4 + C7H11N3O2 170.0930 - - - - - 
Metronidazole (MNZ) 5.4 + C6H9N3O3 172.0722 C6H11N2O C5H9N3O C6H10N2O C6H11N3 C5H9N3 
Ronidazole (RNZ) 12.1 - C6H8N4O4 199.0467 C5H6N2O4 C3N2O2 C4H4N3 - - 
Amphenicols                   
Amoxicillin 4.2 + C16H19N3O5S 366.1123 - - - - - 
Ampicillin 4.2 + C16H19N3O4S 350.1174 C7H7N C6H9NO2S C10H7NO2 C8H7N C4H3NOS 
Cefaclor 3.9 + C15H14N3O4SCl 368.0472 - - - - - 
Cefadroxil 4.9 + C16H17N3O5S 364.0967 - - - - - 
Cefotaxim 4.0 + C16H17N5O7S2 456.0647 C14H13N5O5S2 C12H13N5O2S2 C6H4N4OS C7H6N2OS C13H13N5O4S2 
Ceftriaxone  11.3 + C18H18N8O7S3 555.0539 - - - - - 
Cefuroxime 9.0 + C16H16N4O8S 425.0767 - - - - - 
Cephalexin 3.9 + C16H17N3O4S 348.1018 C6H7NO2S C6H5NOS C10H7NO2 C8H7N C7H7N 
Chlortetracycline 6.1 + C22H23ClN2O8 479.1221 C22H20NO8Cl C9H5O3Cl - - - 
Ciprofloxacin 4.2 + C17H18N3O3F 332.1410 C17H16N3O2F C12H7N2O2F C14H13N2OF C11H7N2OF C16H18N3OF 
Clarithromycin 10.3 + C38H69NO13 748.4847 C30H55NO10 C8H15NO2 C29H51NO9 C6H13NO C5H6O 
Cloxacillin 9.4 + C19H18ClN3O5S 436.0734 C6H9NO2S C19H17NaClN3O5S C9H4NOCl C13H9N2O3Cl C11H8NO2Cl 
Dicloxacillin 10.0 + C19H17Cl2N3O5S 470.0344 C13H8N2O3Cl2 C19H16NaCl2N3O5S C14H5N3O3Cl2 C11H7NOCl2 C9H5NCl2 
Doxycycline 7.2 + C22H24N2O8 445.1611 - - - - - 
Enrofloxacin 4.4 + C19H22FN3O3 360.1723 C18H22N3OF C14H13N2OF C19H20N3O2F - - 
Erythromycin A 9.3 + C37H67NO13 734.4690 C8H15NO2 C37H65NO12 C6H13NO C29H53NO10 - 
Florfenicol 4.5 + C12H14Cl2FNO4S 358.0083 C8H9NO2FCl C6H10NCl C11H6O3FCl C8H8NO2F 
 
Florfenicol amine 1.2 + C10H14FNO3S 248.0757 - - - - - 
Flumequine 8.1 + C14H12NO3F 262.0879 C11H4NO2F C10H4NOF C14H9NO2F C14H11NO2F - 
Lincomycin 3.6 + C18H34N2O6S 407.2216 C8H15N - - - - 
Nalidixic acid 7.7 + C12H12N2O3 233.0926 C10H6N2O2 C12H10N2O2 C9H6N2O - - 
Norfloxacin 4.0 + C16H18N3O3F 320.1410 C16H16N3O2F C13H13N2OF C15H18N3OF C16H15N3O2 C12H7N2O2F 
Ofloxacin 3.9 + C18H20N3O4F 362.1516 C7H20N3O2F C14H13N2O2F C18H18N3O3F C14H9N2O2F C4H7N 
Oxacillin 9.0 + C19H19N3O5S 402.1124 C13H10N2O3 C6H9NO2S C19H18NaN3O5S C14H7N3O3 C11H10N3O3S 
Oxolinic acid 6.4 + C13H11NO5 262.0715 C13H9NO4 C11H5NO4 C10H5NO2 C9H5NO2 C11H4NO4 
Oxytetracycline 4.5 + C22H24N2O9 461.1560 C22H22N2O8 C22H19NO8 C22H21NO9 C22H17NO7 C20H12O8 
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Pharmaceutical 
Rt Ion Elemental 
composition 
[M+H]+ Fragment Fragment Fragment Fragment Fragment 
(min) mode /[M-H]- ion 1 ion 2 ion 3 ion 4 ion 5 
Pefloxacin 3.9 + C17H20FN3O3 334.1567 C17H18N3O2F C13H13N2OF C16H20N3OF C11H9N2OF C11H7N2OF 
Penicillin G 7.9 + C16H18N2O4S 335.1065 C10H9NO2 C6H9NO2S C16H17NaN2O4S C8H9N2O2S C8H7NO2S 
Pipedimic acid 3.3 + C14H17N5O3 304.1409 C14H15N5O2 C11H12N4O C10H6N4O2 C9H8N4O C8H7N3O 
Piperacillin 7.9 + C23H27N5O7S 518.1709 C14H15N5O7S C6H10N2O2 C6H9NO2S C23H26N5NaO7S C17H18N4O5 
Roxythromycin 10.5 + C41H76N2O15 837.5324 C33H62N2O12 C8H15NO2 C5H6O C35H60N2O12 C28H45N2O7 
Sarafloxacin 4.9 + C20H17F2N3O3 386.1316 C20H15N3O2F2 C20H11N2F C19H17N3OF2 C17H20N3O2F - 
Sulfadoxine 4.8 + C12H14N4O4S 311.0814 C6H5NO2S C12H13N4O4SNa C6H5NO C6H7N3O2 C5H5N3O2 
Sulfamethoxazole 4.4 + C10H11N3O3S 254.0599 C6H5NO2S C6H5N C6H5NO C4H6N2O - 
Tetracycline 4.4 + C22H24N2O8 445.1611 C22H19NO7 C7H7NO3 - - - 
Thiamphenicol 3.4 + C12H15Cl2NO5S 356.0126 C11H8NOCl2 C11H8NOCl C9H7O - - 
    - C12H15Cl2NO5S 353.9970 C8H10O3S C8H8O CH4O2S C11H14NO4SCl C12H13NO5S 
Trimethoprim 3.6 + C14H18N4O3 291.1457 C12H12N4O3 C14H15NO2 C12H13N4O C13H14N4O3 C13H12N4O2 
Avermectins 
 
    
  
        
Abamectine B1a 15.4 + C48H71O14Na 895.4820 C48H72O14 - - - - 
Doramectine 16.8 + C50H74O14 899.5157 C50H74O14Na C50H74O14K - - - 
Emamectin B1a 13.5 + C49H75NO13 886.5317 C7H11NO C49H75NO13Na C12H13 C19H25O3 - 
Eprinomectin 14.9 + C50H75NO14 914.5266 C50H75NO14Na C6H9NO C15H23NO5 C9H15NO3 C8H11NO2 
Ivermectin 16.0 + C48H74O14 875.5157 C48H73O14Na - - - - 
Levamisole 2.8 + C11H12N2S 205.0799 C10H11NS C7H6 C7H6S C10H8 - 
Moxidectin 15.6 + C37H53NO8 640.3849 C29H37NO6 C30H41NO7 C37H53NO8Na C37H53NO8K C29H41NO6 
Coccidiostats                   
Maduramicine 15.5 + C47H79O17Na 939.5293 C46H77O14Na C42H77O18Na C37H56O8 - - 
Monensin 15.1 + C36H62O11 671.4370 C36H61O11Na C36H61O11K C28H44O5 C36H59O10Na - 
    - C36H62O11 669.4214 C35H58O10 C11H20O2 C5H10O2 C4H8O2 - 
Narasin 16.1 + C43H72O11 765.5153 C13H20O3 C23H32O4 C43H72O11Na C42H68O10 C42H66O9 
    - C43H72O11 763.4996 C23H36O6 C20H36O5 C19H29O5 C14H24O4 C13H24O2 
Robenidine 10.8 + C15H13Cl2N5 334.0626 C8H4N3Cl C7H7N2Cl C7H5Cl C8H7N4Cl C7H6NCl 
Salinomycin 15.7 + C42H70O11 751.4996 C42H70O11Na C42H70O11K C42H68O10 C42H66O9 - 
    - C42H70O11 749.4840 C19H30O5 C35H60O11 C23H36O6 C19H34O5 - 
Sedatives                   
Acepromazine 8.8 + C19H22N2OS 327.1531 C5H11N C15H12NS C13H9NS C17H15NOS C15H11NOS 
Alprazolam 9.6 + C17H13ClN4 309.0907 C16H11N3Cl C17H13N4 C15H4N4 C14H8N2 C8H5N2Cl 
Azaperol 5.0 + C19H24FN3O 330.1982 C10H9F C7H8N2 C19H22N3F C12H14NF C9H12N2 
Azaperone 5.6 + C19H22FN3O 328.1825 C10H9OF C7H3OF C7H10N2 C9H10N2 - 
Carazolol 6.0 + C18H22N2O2 299.1760 C15H11NO C12H9NO C6H13NO C3H7NO C13H9NO 
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Pharmaceutical 
Rt Ion Elemental 
composition 
[M+H]+ Fragment Fragment Fragment Fragment Fragment 
(min) mode /[M-H]- ion 1 ion 2 ion 3 ion 4 ion 5 
Chlorpromazine 10.1 + C17H19ClN2S 319.1036 C13H8NCl C5H11N C15H12NSCl C13H8NSCl C13H8NS 
Propionilpromazine (combelen) 9.8 + C20H24N2OS 341.1688 C16H13NOS C5H11N C16H13NO C18H17NOS C3H7N 
Non steroidal anti-inflammatory (NSAIDs) 
  
        
4-Acetylamino-antipyrine 3.6 + C13H15N3O2 246.1242 C13H15N3O2 C13H13N3O C11H13N3O C7H5N C10H10N2 
4-amino-antipyrine  3.5 + C11H13N3O 204.1137 C4H6N2 C7H5N C4H6N2 C6H7N C6H7N 
4-formylamino-antipyrine 3.5 + C12H13N3O2 232.1086 C12H12N3O2Na C12H12N3O2K C7H5N C4H6N2 C6H7NO 
Diclofenac 12.1 + C14H11Cl2NO2 296.0245 C14H10NaCl2NO2 C14H9NOCl2 C13H8NCl C13H9NCl - 
    - C14H11Cl2NO2 294.0089 C13H9NCl2 C13H8NCl - - - 
Ibuprofen 12.4 - C13H18O2 205.1229 C12H16 - - - - 
Ketoprofen 10.1 + C16H14O3 255.1021 C16H13NaO3 C15H12O C14H9O C7H4O - 
    - C16H14O3 253.0865 C15H12O C13H8O2 - - - 
Mefenamic acid 13.2 + C15H15NO2 242.1181 C15H13NO C14H10NO C13H9N - - 
Naproxen 10.4 + C14H14O3 231.1021 C13H12O C12H9O C14H13NaO3 C12H8 C11H8 
Oxyphenylbutazone 9.8 + C19H20N2O3 325.1552 C19H19N2O3Na C12H13NO2 C8H5NO2 C7H5NO C11H13N 
Phenylbutazone 11.4 + C19H20N2O2 309.1603 C12H13NO C11H13N C7H5NO C8H5NO C6H5N 
Salicylic acid 5.2 - C7H6O3 137.0239 C6H4O - - - - 
Corticoids                   
Betamethasone o Dexamethasone 9.9 + C22H29FO5 393.2077 C22H28O5 C22H26O4 C22H24O3 C22H22O2 C21H22O2 
Flumethasone 9.5 + C22H28F2O5 411.1983 C17H16O2 C14H15O2F C8H8O C9H10O - 
Methylprednisolone 9.9 + C22H30O5 375.2171 C13H12O C11H12O C20H22O C17H16O C12H12O 
Parasiticide                   
Leucomalachite green 12.6 + C23H26N2 331.2171 C14H13N C16H18N2 C13H9N C22H23N2 C17H20N2 
Malachite green 9.7 + C23H25ClN2 365.1785 C23H24N2 C22H20N2 C15H13N C17H17N2   
Other pharmaceuticals                   
Acetaminophen 2.2 + C8H9NO2 152.0711 C6H7NO C6H5N C6H4O C8H7NO C8H7NO2 
Atorvastatin 11.9 + C33H35FN2O5 559.2608 C26H30NO4F C20H18NF C33H34NaFN2O5 C27H28NO5F C19H14NF 
    - C33H35FN2O5 557.2452 C29H25N2O2F C26H21N2OF - - - 
          
Bezafibrate 10.6 + C19H20ClNO4 362.1159 C18H18NO2Cl C15H14NO2Cl C11H12O C7H3OCl C8H8O 
    - C19H20ClNO4 360.1003 C15H12NO2Cl C7H4NOCl C3H2NO2 - - 
Carbamazepine  8.1 + C15H12N2O 237.1028 C14H10N C14H11N C13H8N - - 
    - C15H12N2O 235.0871 C14H12N C14H11N C14H10N C13H9N - 
Enalapril 7.8 + C20H28N2O5 377.2076 C14H19NO2 C14H19NO2 C11H13N C17H22N2O3 C9H11N 
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Pharmaceutical 
Rt Ion Elemental 
composition 
[M+H]+ Fragment Fragment Fragment Fragment Fragment 
(min) mode /[M-H]- ion 1 ion 2 ion 3 ion 4 ion 5 
Gemfibrozil 13.3 + C15H22O3 251.1647 C15H21NaO3 C7H12O2 C15H20O2 - - 
  13.3 - C15H22O3 249.1491 C8H8O - - - - 
Irbesartan 10.6 + C25H28N6O 429.2403 C14H10N2 C11H18N2O C13H9N C14H9N - 
    - C25H28N6O 427.2246 C11H18N2O C25H28N4O - - - 
Lorazepam 9.6 + C15H10Cl2N2O2 321.0198 C14H8N2Cl2 C13H9N2Cl C15H9NaCl2N2O2 C15H8N2OCl2 C14H7N2Cl 
Olanzapine 3.7 + C17H20N4S 313.1487 C14H13N3S C12H8N2S C16H15N3S C11H5N2S C11H7NS 
Omeprazole 7.8 + C17H19N3O3S 346.1225 C9H11NO2S C9H11NO C8H8N2O C9H9NOS C8H6NOS 
Pantoprazole 8.1 + C16H15F2N3O4S 384.0830 C7H7NO2 C8H9NO3S C8H10NO2 - - 
Pravastatin 9.8 + C23H36O7 425.2539 C23H35NaO7 C20H22O4 - - - 
    - C23H36O7 423.2383 C5H10O2 C18H24O4 C11H12 - - 
Valsartan  11.0 + C24H29N5O3 436.2349 C24H28N5O3Na C18H19N5 C14H10N4 C24H27N5O2 C24H29N3O3 
    - C24H29N5O3 434.2192 C14H12 C14H11 C19H21N5O2 - - 
Venlafaxine 7.0 + C17H27NO2 278.2120 C17H25NO C8H8O C15H18O - - 
Molecular formulae of the fragment ions differs ±1 hydrogen from the real one, depending on the ionization mode 13 
 14 
 15 
 16 
 17 
 18 
 19 
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Table S2. Validation results obtained after analysis of ten animal feed samples spiked at 0.02 and 0.2 mg 20 
kg-1. Screening detection limits (SDL) and limits of identification (LOI) for each matrix, and SDL of the 21 
method (all in mg kg-1). 22 
Pharmaceutical 
Poultry  
(n=2) 
  
Bovine 
(n=2) 
  
Rabbit 
(n=2) 
  
Pork 
(n=2) 
  
Goat 
(n=2) 
SDL LOI   SDL LOI   SDL LOI   SDL LOI   SDL LOI 
Stilbenes                             
Dienestrol 0.2 0.2   0.2 -   - -   0.2 -   - - 
Diethylstilbestrol  - -   - -   - -   - -   - - 
Hexestrol 0.2 0.2   - -   0.2 -   0.2 0.2   - - 
Steroids   
             
∆1,4-Androstadiene-3,17-dione (Boldione)a 0.02 -   0.2 -   0.2 -   - -   - - 
16-β-hydroxystanozololb - -   - -   - -   - -   - - 
α-Boldenone 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.2 
α-Nandrolone 0.02 0.02   0.02 0.2   0.02 -   0.02 0.02   0.02 0.02 
Androstenediol (AED)a 0.02 -   0.02 -   - -   0.02 -   0.02 - 
β-Boldenone 0.02 0.02   0.02 -   0.02 0.2   0.02 0.02   0.2 0.2 
β-Nandrolone 0.02 0.2   0.02 0.2   0.02 0.02   0.2 0.2   0.02 0.02 
Stanozolol 0.02 0.2   0.02 -   0.02 0.02   0.02 -   0.02 - 
RALs                             
α-Zeranol 0.02 0.2   0.2 0.2   -  -   0.02 0.2   0.2 0.2 
β-Zeranol 0.02 0.2   0.2 0.2   0.02 0.2   0.02 0.2   0.2 - 
Zearalanone (ZAN) - -   - -   0.2 -   - -   - - 
β-Agonists       
  
                
 
Brombuterol 0.02 0.02   0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02 
Clenbuterol 0.02 0.02   0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02 
Clenpenterol 0.02 0.02   0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02 
Hydroxymethyl clenbuterol 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
Mabuterol 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
Mapenterol 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
Ractopamine 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.2 
Nitromidazoles                             
Chloramphenicol 0.02 0.2   0.02 0.2   0.02 0.2   0.02 0.2   0.02 0.2 
Dimetridazole (DMZ) 0.02 -   0.02 -   0.02 0.2   0.02 0.2   0.02 0.02 
Furaltadone 0.02 0.2   0.02 -   0.2 0.2   0.02 0.2   0.02 0.2 
Hydroxy Dimetridazole ( HMMNI) a - -   0.02 -   - -   - -   - - 
Hydroxyipronidazole (IPZOH) 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
Hydroxymetronidazole (MNZOH)a 0.2 -   0.2 -   0.2 -   0.2 -   - - 
Ipronidazole (IPZ)a 0.02 -   0.2 -   0.2 -   0.02 -   0.02 - 
Metronidazole (MNZ) - -   - -   0.02 -   - -   - - 
Ronidazole (RNZ) 0.2 -   0.2 -   - -   0.2 -   - - 
Amphenicols   
             
Amoxicillina - -   - -   - -   - -   - - 
Ampicillin 0.02 0.2   0.2 0.2   0.2 -   0.2 0.2   0.2 0.2 
Cefaclora - -   - -   - -   - -   - - 
Cefadroxila - -   - -   - -   - -   - - 
Cefotaxim 0.02 0.2   0.2 0.2   0.2 0.2   0.02 0.02   0.2 0.2 
Ceftriaxonea - -   0.2 -   - -   - -   - - 
Cefuroximea - -   0.2 -   0.2 -   - -   - - 
Cephalexin - -   - -   - -   - -   - - 
Chlortetracycline  - -   0.2 0.2   0.2 -   0.2 -   0.2 - 
Ciprofloxacin 0.02 0.2   0.2 0.2   0.2 0.2   0.02 0.02   0.2 0.2 
Clarithromycin 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
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Pharmaceutical 
Poultry  
(n=2) 
  
Bovine 
(n=2) 
  
Rabbit 
(n=2) 
  
Pork 
(n=2) 
  
Goat 
(n=2) 
SDL LOI   SDL LOI   SDL LOI   SDL LOI   SDL LOI 
Cloxacillin 0.2 0.2   0.2 0.2   0.02 0.2   0.2 0.2   0.2 0.2 
Dicloxacillin 0.2 0.2   0.2 0.2   0.2 0.2   0.2 0.2   0.2 - 
Doxycyclinea - -   - -   0.02 -   0.02 -   0.02 - 
Enrofloxacin 0.02 0.2   0.02 0.2   0.2 0.2   0.02 0.2   0.02 0.2 
Erythromycin A 0.2 0.2   0.2 0.2   0.2 -   0.2 -   0.2 - 
Florfenicol 0.2  -   0.2 0.2   0.02 0.02   0.2 0.2   0.2 0.2 
Florfenicol aminea 0.2 -   0.2 -   - -   0.2 -   - - 
Flumequine 0.02 0.2   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
Lincomycinb 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
Nalidixic acid 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
Norfloxacin 0.02 0.2   0.2 0.2   0.02 0.2   0.02 0.02   0.2 0.2 
Ofloxacin 0.02 0.2   0.2 0.2   0.02 0.2   0.02 0.02   0.02 0.2 
Oxacillin 0.2 0.2   0.2 0.2   0.2 0.2   0.2 0.2   0.2 - 
Oxolinic acid 0.02 0.02   0.2 0.2   0.02 0.2   0.02 0.02   0.02 0.2 
Oxytetracycline - -   0.2 0.2   0.02 0.02   0.02 0.02   - - 
Pefloxacin 0.02 0.02   0.02 0.2   0.02 0.2   0.02 0.2   0.02 0.2 
Penicillin G 0.2 0.2   0.02 0.2   0.02 0.2   0.2 0.2   0.2 0.2 
Pipedimic acid 0.2 0.2   0.2 0.2   0.02 0.2   0.2 0.2   0.02 0.2 
Piperacillin 0.2 0.2   0.02 0.2   0.2 0.2   0.2 0.2   0.2 0.2 
Roxythromycin 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
Sarafloxacin 0.02 0.2   0.02 0.2   0.2 -   0.02 0.2   0.2 0.2 
Sulfadoxine 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
Sulfamethoxazole 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.2   0.02 0.2 
Tetracycline - -   0.2 -   - -   0.02 0.02   - - 
Thiamphenicol 0.02 -   0.2 -   0.02 -   0.02 0.2   0.02 - 
Trimethoprim 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
Avermectins                             
Abamectine B1ab - -   - -   - -   - -   - - 
Doramectine - -   - -   - -   - -   - - 
Emamectin B1a 0.02 0.02   0.02 0.2   0.02 0.02   0.2 0.2   0.02 0.2 
Eprinomectin 0.2  -   0.2 -   0.2 -   0.2 0.2   0.2 0.2 
Ivermectinb 0.2 -   - -   - -   0.2 -   - - 
Levamisole 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.2 
Moxidectin 0.2 0.2    0.2 -   - -   0.2 0.2   0.2 0.2 
Coccidiostats       
  
                
 
Maduramicine 0.02 0.2   0.02 0.2   0.02 0.2   0.02 0.2   0.02 0.2 
Monensin 0.02 0.02   0.02 0.2   0.2 0.2   0.2 0.2    0.2 0.2 
Narasin 0.02 0.2   0.02 0.2   0.02 0.2   0.02 -   0.02 0.2 
Robenidine 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.2 
Salinomycin 0.02 0.02   0.2 0.2   0.2 0.2   0.2 -   0.2  - 
Sedatives                             
Acepromazine 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.2 
Alprazolam 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.2 
Azaperol 0.02 0.02   0.02 0.02   0.02 0.2   0.02 0.02   0.02 - 
Azaperone 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
Carazolol 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
Chlorpromazine 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
Propionilpromazine (combelen) 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
NSAIDs       
  
                  
4-acetylamino-antipyrine 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
4-amino-antipyrine  0.2 0.2   0.02 -   0.2 -   0.02 -   - - 
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Pharmaceutical 
Poultry  
(n=2) 
  
Bovine 
(n=2) 
  
Rabbit 
(n=2) 
  
Pork 
(n=2) 
  
Goat 
(n=2) 
SDL LOI   SDL LOI   SDL LOI   SDL LOI   SDL LOI 
4-formylamino-antipyrine 0.02 0.2   0.02 0.2   0.2 0.2   0.02 0.02   0.02 0.02 
Diclofenac 0.2 0.2   0.2 0.2   0.2 0.2   0.02 0.02   0.2 0.2 
Ibuprofenb - -   - -   - -   0.2 0.2   - -  
Ketoprofen 0.02 0.02   0.02 0.2   0.02 0.2   0.02 0.02   0.02 0.2 
Mefenamic acid 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
Naproxen 0.2 0.2   0.2 0.2   0.02 0.2   0.2 0.2   0.02 - 
Oxyphenylbutazone 0.02 0.2   0.2 0.2   0.2 -   0.02 0.2   0.2 - 
Phenylbutazone 0.2 0.2   0.2 0.2   0.2 -   0.02 0.2   - - 
Salicylic acidb 0.02 -   0.02 -   0.02 -   0.02 -   0.02 0.2 
Corticoids       
  
                
 
Betamethasone/Dexamethasone 0.2 0.2   0.2 0.2   0.2 -    0.2 0.2   0.2 0.2 
Flumethasone 0.2 0.2   0.2 -   0.2 0.2    0.2 0.2   0.2 - 
Methylprednisolone - -   0.2 -   - -   0.2 0.2   - - 
Parasiticide                             
Leucomalachite green 0.02 0.02   - -   - -   0.2 0.2   0.2 0.2 
Malachite green 0.02 0.02   0.02 0.02   0.02 0.2   0.2 0.2    0.02 0.02 
Other pharmaceuticals                             
Acetaminophen 0.2 -   0.2 -   0.2 -   0.2  -   - - 
Atorvastatin 0.2 0.2   0.2 0.2   0.2 -   0.2 0.2   0.2 0.2 
Bezafibrate 0.02 0.2   0.02 0.2   0.2 0.2   0.02  -   0.02 - 
Carbamazepine 0.02 0.02   0.02 0.2   0.02 0.02   0.02  -   0.02 0.02 
Enalapril 0.02 0.02   0.02 0.2   0.02 0.2   0.02 0.02   0.02 0.02 
Gemfibrozil 0.02 0.02   0.2 0.2   0.2c 0.2c   0.2 0.2   0.2c 0.2c 
Irbesartan 0.02 0.02   0.02 0.2   0.02 0.02   0.02 0.02   0.02 0.02 
Lorazepam 0.2 0.2   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
Olanzapine 0.02 0.02   0.2 0.2   0.2 0.2   0.02 0.02   0.2 0.2 
Omeprazole - -   - -   - -   -  -   - - 
Pantoprazole 0.2 0.2   0.2 0.2   - -   0.2  -   - - 
Pravastatin 0.02 0.2   0.2 0.2   0.02 0.2   0.02 0.02    0.02 0.2 
Valsartan 0.02 0.02   0.02 0.02   0.2 0.2   0.02 0.02   0.02 0.02 
Venlafaxine 0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02   0.02 0.02 
a 
Compound without fragment ions 23 
b 
Compound with only one fragment ion 24 
c 
Found in negative ionization mode 25 
 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
41 
 
 41 
Table S3. Recovery experiments for the compounds detected in feed samples. 42 
 43 
Compound 
Ionization 
mode 
  Recovery (RSD) (both in %)   
Isotopically-labelled internal 
standard (ILIS)  Bovine (n=3) 
 
Poultry (n=3) 
 
Pork (n=3) 
 
 
0.2 mg kg-1 
 
2 mg kg-1 
 
0.2 mg kg-1 
 
2 mg kg-1 
 
0.2 mg kg-1 
 
2 mg kg-1 
 
β-Nandrolone + 
 
94 (14) 
 
144 (3) 
 
76 (15) 
 
123 (3) 
 
93 (5) 
 
110 (4) 
 
Fenilbutazone-d10 
Robenidine + 
 
93 (6) 
 
94 (3) 
 
61 (3) 
 
90 (3) 
 70 (1) 
 
98 (6) 
 
Robenidine-d8 
Chlortetracycline + 
 
- 
 
- 
 
- 
 
- 
 
- 
 
81 (22) 
 
Amphetamine-d6 
Oxytetracycline + 
 
- 
 
- 
 
- 
 
- 
 - 
 
108 (9) 
 
Amphetamine-d6 
Tetracycline + 
 
- 
 
- 
 
- 
 
- 
 
- 
 
101 (4) 
 
Amphetamine-d6 
Doxicycline + 
 
- 
 
- 
 
- 
 
- 
 
- 
 
115 (11) 
 
Amphetamine-d6 
Lincomycin + 
 
105 (1) 
 
121 (2) 
 
92 (0) 
 
104 (2) 
 
- 
 
- 
 
Carbamazepine epoxide-d10 
Trimethoprim + 
 
57 (5) 
 
120 (2) 
 
51 (0) 
 
96 (6) 
 
33 (7) 
 
85 (2) 
 
Fenilbutazone-d10 
Florfenicol + 
 
73 (8) 
 
58 (4) 
 
71 (9) 
 
98 (2) 
 
59 (10) 
 
81 (10) 
 
Benzoylecgonine-d3 
Acid salicylic -   -   108 (10)   -   39 (19)   -   132 (7)   4,4’dinitrocarbanilide-d8 
 44 
 45 
 46 
 47 
42 
 
 48 
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SCREENING DETECTION LIMIT (SDL)
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-(de)protonated molecule
(b)
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LIMIT OF IDENTIFICATION (LOI)
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 49 
Figure S1. Number of analytes (a) detected and (b) identified at 0.02 and 0.2 mg kg-1 50 
in each feed matrix.51 
43 
 
 
 
 
 
 
 
 
 
 
 
 
 63 
 64 
 65 
 66 
 67 
 68 
 69 
 70 
Figure S2. Absolute response for six pharmaceuticals in solvent and in five feed matrices spiked at 0.2 mg kg-1. 71 
44 
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 72 
Figure S3. HE mass spectra of trimethoprim in (a) reference standard and (b) poultry feed sample. 73 
 74 
 75 
